Asset Details
Do you wish to reserve the book?
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Do you wish to request the book?
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
2011
Overview
Limited data on the efficacy of the quadrivalent HPV vaccine are available for males. In this trial involving 4065 healthy boys and young men 16 to 26 years of age, the quadrivalent vaccine against HPV reduced the occurrence of external genital lesions by 60%.
Human papillomavirus (hpv) infects the squamous epithelium in both sexes, leading to anogenital condylomata acuminata and, in males, to cancers of the penis, anus, and oropharynx.
1
The rate of genital HPV infection among males is similar to that in females. In any 12-month period, the probability that a sexually active male will acquire a new genital HPV infection is 0.29 to 0.39,
2
–
4
which is similar to estimates for females. However, there are differences between the sexes in the immune response to HPV. A larger proportion of females are HPV-seropositive (17.9%, vs. 7.9% of males), and females . . .
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Biological and medical sciences
/ Females
/ Genital Diseases, Male - epidemiology
/ Genital Diseases, Male - prevention & control
/ Genital Diseases, Male - virology
/ Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
/ Humans
/ Injections - adverse effects
/ Male
/ Males
/ Papillomavirus Infections - epidemiology
/ Papillomavirus Infections - prevention & control
/ Papillomavirus Infections - virology
/ Papillomavirus Vaccines - adverse effects
/ Public health. Hygiene-occupational medicine
/ Vaccines
